Wednesday, February 10, 2021 12:55:28 PM
I know many on this board play the OTC like it’s Fantasy Football (or hockey for our Canadian friends), watching it minute by minute. I admit, I’ve got enough shares that I loose or gain a lot of money with each penny movement. But, I’m calm. Why?
Maybe I have a better handle on my emotions, or I don’t have attention deficit disorder, or maybe it’s because:-
- Pharm Olam has a wonderful reputation on trial study performance.
- Prior to the trial, Dr. Kelly McKee was enthusiastic about the Bucillamine hypothesis with regards to Covid.
- The trial itself is considered a Gold Standard, and any data released before all the data is in, would actually be bad news.
- There are indications of positive trial results, with out the data.
1) Frank’s comments in PR prior to Christmas
2) Adding sites in January
3) Funding from large investors, which sets the new floor in share price until news does break.
4) Hiring Research Doctor, in Fahy, that has overseen a Thiol Donor study.
I’ve always said trust the science, and the UCSF study was more encouraging than I had ever hoped for.
Good news is coming and the market is larger than just North America.
FEATURED Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM
BNCM COMPLETES MERGER WITH DELEX HEALTHCARE • BNCM • Oct 8, 2024 9:54 AM
CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 • CBDL • Oct 8, 2024 8:00 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM